Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation
Clinical trial NCT06021509 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06021509
- Sponsor
- Enlight Medical Technologies (Shanghai) Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-15
- Primary completion
- 2024-06-25
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.